Mast cells and de novo angiogenesis: angiogenic capability of individual mast-cell mediators such as histamine, TNF, IL-8 and bFGF.
Norrby
K
K
Department of Pathology, Sahlgrenska University Hospital, Göteborg, Sweden.
D000818:Animals; D016228:Endothelial Growth Factors / Q000494:pharmacology; D016222:Fibroblast Growth Factor 2 / Q000494:pharmacology*; D006632:Histamine / Q000494:pharmacology*; D016209:Interleukin-8 / Q000494:pharmacology*; D008222:Lymphokines / Q000494:pharmacology; D008297:Male; D008407:Mast Cells / Q000502:physiology*; D008643:Mesentery; D018919:Neovascularization, Physiologic; D051381:Rats; D017207:Rats, Sprague-Dawley; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology*; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors
D016228:Endothelial Growth Factors; D016209:Interleukin-8; D008222:Lymphokines; D014409:Tumor Necrosis Factor-alpha; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors; D016222:Fibroblast Growth Factor 2; D006632:Histamine